Ichiro Tsukimoto

Risk-Stratified Therapy and the Intensive Use of Cytarabine Improves the Outcome in Childhood Acute Myeloid Leukemia: The AML99 Trial From the Japanese Childhood AML Cooperative Study Group

Ichiro Tsukimoto, Akio Tawa, Keizo Horibe et al. · Journal of Clinical Oncology · 2009 · 233 citations · Full text

Surface Markers and Prognostic Factors in Acute Lymphoblastic Leukemia

Ichiro Tsukimoto, Kwan Y. Wong, Beatrice C. Lampkin · New England Journal of Medicine · 1976 · 229 citations

Hematological Malignancy, Lymphoid Neoplasia, Oncology +11

Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia

Seiji Kojima, Yoshiyuki Kosaka, Masuji Yamamoto et al. · Blood · 2000 · 217 citations

Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia

Seiji Kojima, Shigeyoshi Hibi, Yoshiyuki Kosaka et al. · Blood · 2000 · 205 citations

Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children

Seiji Kojima, Akira Ohara, Masahiro Tsuchida et al. · Blood · 2002 · 192 citations · Full text